Drug
Aripiprazole Product
Aripiprazole Product: highest development phase Phase 3, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| Aripiprazole oral product NCT00870727 | Phase 3 | Pervasive Developmental Disorder |
Latest
No recent events.
Follow Aripiprazole Product on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.